Grabow S - Search Results

1

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival.

Viant C, Guia S, Hennessy RJ, Rautela J, Pham K, Bernat C, Goh W, Jiao Y, Delconte R, Roger M, Simon V, Souza-Fonseca-Guimaraes F, Grabow S, Belz GT, Kile BT, Strasser A, Gray D, Hodgkin PD, Beutler B, Vivier E, Ugolini S, Huntington ND. Viant C, et al. Among authors: grabow s. J Exp Med. 2017 Feb;214(2):491-510. doi: 10.1084/jem.20160869. Epub 2017 Jan 5. J Exp Med. 2017. PMID: 28057804 Free PMC article.

2

Antagonism between MCL-1 and PUMA governs stem/progenitor cell survival during hematopoietic recovery from stress.

Delbridge AR, Opferman JT, Grabow S, Strasser A. Delbridge AR, et al. Among authors: grabow s. Blood. 2015 May 21;125(21):3273-80. doi: 10.1182/blood-2015-01-621250. Epub 2015 Apr 6. Blood. 2015. PMID: 25847014 Free PMC article.

3

RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice.

Delbridge AR, Pang SH, Vandenberg CJ, Grabow S, Aubrey BJ, Tai L, Herold MJ, Strasser A. Delbridge AR, et al. Among authors: grabow s. J Exp Med. 2016 Sep 19;213(10):2039-48. doi: 10.1084/jem.20150477. Epub 2016 Sep 12. J Exp Med. 2016. PMID: 27621418 Free PMC article.

4

Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL-XL (BCL2L1).

Delbridge AR, Chappaz S, Ritchie ME, Kile BT, Strasser A, Grabow S. Delbridge AR, et al. Among authors: grabow s. Br J Haematol. 2016 Sep;174(6):962-9. doi: 10.1111/bjh.14155. Epub 2016 May 25. Br J Haematol. 2016. PMID: 27221652 Free article.

5

Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.

Kelly PN, Grabow S, Delbridge AR, Strasser A, Adams JM. Kelly PN, et al. Among authors: grabow s. Blood. 2011 Dec 8;118(24):6380-6. doi: 10.1182/blood-2011-07-367672. Epub 2011 Oct 12. Blood. 2011. PMID: 21998213 Free PMC article.

6

MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient mice.

Grabow S, Delbridge AR, Valente LJ, Strasser A. Grabow S, et al. Blood. 2014 Dec 18;124(26):3939-46. doi: 10.1182/blood-2014-09-601567. Epub 2014 Nov 3. Blood. 2014. PMID: 25368374 Free article.

7

Impact of the combined loss of BOK, BAX and BAK on the hematopoietic system is slightly more severe than compound loss of BAX and BAK.

Ke F, Grabow S, Kelly GL, Lin A, O'Reilly LA, Strasser A. Ke F, et al. Among authors: grabow s. Cell Death Dis. 2015 Oct 22;6(10):e1938. doi: 10.1038/cddis.2015.304. Cell Death Dis. 2015. PMID: 26492371 Free PMC article.

8

Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies.

Delbridge AR, Grabow S, Strasser A, Vaux DL. Delbridge AR, et al. Among authors: grabow s. Nat Rev Cancer. 2016 Feb;16(2):99-109. doi: 10.1038/nrc.2015.17. Nat Rev Cancer. 2016. PMID: 26822577 Review.

9

Physiological restraint of Bak by Bcl-xL is essential for cell survival.

Lee EF, Grabow S, Chappaz S, Dewson G, Hockings C, Kluck RM, Debrincat MA, Gray DH, Witkowski MT, Evangelista M, Pettikiriarachchi A, Bouillet P, Lane RM, Czabotar PE, Colman PM, Smith BJ, Kile BT, Fairlie WD. Lee EF, et al. Among authors: grabow s. Genes Dev. 2016 May 15;30(10):1240-50. doi: 10.1101/gad.279414.116. Epub 2016 May 19. Genes Dev. 2016. PMID: 27198225 Free PMC article.

10

Combined reduction in the expression of MCL-1 and BCL-2 reduces organismal size in mice.

Ke F, Lancaster GI, Grabow S, Murphy AJ, Strasser A. Ke F, et al. Among authors: grabow s. Cell Death Dis. 2020 Mar 13;11(3):185. doi: 10.1038/s41419-020-2376-5. Cell Death Dis. 2020. PMID: 32170090 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters